NASDAQ:SPRO - Spero Therapeutics Price Target & Analyst Ratings

$12.07
+0.13 (+1.09 %)
(As of 09/16/2019 12:40 PM ET)
Today's Range
$11.55
Now: $12.07
$12.29
50-Day Range
$9.05
MA: $10.01
$12.24
52-Week Range
$5.52
Now: $12.07
$14.48
Volume41,534 shs
Average Volume35,927 shs
Market Capitalization$225.23 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

Analyst Ratings

Spero Therapeutics (NASDAQ:SPRO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Spero Therapeutics in the last 12 months. Their average twelve-month price target is $23.50, suggesting that the stock has a possible upside of 94.70%. The high price target for SPRO is $30.00 and the low price target for SPRO is $9.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldBuy
Consensus Rating Score: 2.602.502.332.50
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.50$23.25$22.00$23.50
Price Target Upside: 94.70% upside151.90% upside93.32% upside81.89% upside

Spero Therapeutics (NASDAQ:SPRO) Consensus Price Target History

Spero Therapeutics (NASDAQ:SPRO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/9/2019Janney Montgomery ScottInitiated CoverageBuyHigh
9/4/2019HC WainwrightReiterated RatingBuy$28.00Medium
5/9/2019Cantor FitzgeraldReiterated RatingBuy$27.00High
2/26/2019OppenheimerSet Price TargetBuy$30.00Low
10/16/2018Bank of AmericaDowngradeNeutral ➝ Underperform$19.00 ➝ $9.00High
11/27/2017Stifel NicolausInitiated CoverageBuy ➝ Buy$26.00High
11/27/2017CowenInitiated CoverageOutperformHigh
(Data available from 9/16/2017 forward)
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel